Page 14 - David Ricks News Today

Shares of Korea-listed Caregen surged on hope its diabetes-weight loss supplement could give the little-known biotech company an Ozempic-like boost. But then the stock crashed.

More headlines on the horizon.

More headlines on the horizon.

A breakdown of who donated to each Indiana gubernatorial campaign in 2023, and on what the candidates spent their money.

District schedules workshops in Jay

NL Correspondent Jammu Tawi: BioAsia - the marquee healthcare and Life Sciences event, organized by the Government of Telangana, is all set for the grand unveiling of its 21st edition in Hyderabad.Sri Duddilla Sridhar Babu, Minister for Information Technology, Industries & Commerce conducted a comprehensive review of the preparations for the upcoming global conference. As

New Delhi : BioAsia - the marquee healthcare and Life Sciences event, organized by the Government of Telangana, is all set for the grand unveiling of its 21st edition in Hyderabad. Sri Duddilla Sridhar Babu, Minister for Information Technology, Indus

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will...

Pharmaceutical executives from Amgen to Pfizer are plotting to break into the lucrative obesity market by developing or cutting deals to acquire better drugs that will compete with Novo Nordisk's Wegovy and Zepbound from Eli Lilly. Amgen has an experimental dual mechanism obesity drug in mid-stage trials it hopes will have fewer side effects with less frequent dosing than Wegovy or Zepbound, Chief Scientific Officer Jay Bradner told Reuters at the annual JPMorgan health conference in San F...

The CEOs of Eli Lilly and Novo Nordisk addressed nagging questions at the 2024 J.P. Morgan Healthcare Conference.